PHP 501 trifluoroacetate |
Catalog No.GC13557 |
GABAA antagonist
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1236105-75-1
Sample solution is provided at 25 µL, 10mM.
GlpBio Products Cited In Reputable Papers
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Cas No. | 1236105-75-1 | SDF | |
Chemical Name | 5-([1,1'-biphenyl]-3-yl)-4-(piperidin-4-yl)-1H-pyrazol-1-ol 2,2,2-trifluoroacetate | ||
Canonical SMILES | ON1C(C2=CC=CC(C3=CC=CC=C3)=C2)=C(C4CCNCC4)C=N1.FC(F)(F)C(O)=O | ||
Formula | C20 H21 N3 O . C2 H F3 O2 | M.Wt | 433.42 |
Solubility | <43.34mg/ml in DMSO | Storage | Store at -20°C |
General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. |
Complete Stock Solution Preparation Table
Prepare stock solution | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.3072 mL | 11.5362 mL | 23.0723 mL |
5 mM | 0.4614 mL | 2.3072 mL | 4.6145 mL |
10 mM | 0.2307 mL | 1.1536 mL | 2.3072 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC31257 Rilmazafone hydrochloride (450191S)
- GC18811 CAY10471
- GC35401 Asatone
- GC37540 Risperidone mesylate
- GC45724 Corticosterone-d8
- GC18262 Acetamiprid
- GC19192 HMN-176
- GC34513 C25-140
- GC40376 15-OxoETE
- GC14057 GSK1349572 sodiuM salt
- GC33329 SLLK, Control Peptide for TSP1 Inhibitor
- GC44022 L-858,051 (hydrochloride)
- GC15597 AT7519 trifluoroacetate
- GC36578 MD2-TLR4-IN-1
- GC33550 LCB-2853
- GC17381 trans-4-Hydroxycrotonic acid
Reviews
Average Rating: 5 ★★★★★ (Based on Reviews and 12 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *